Evidence map›Paper›PMID 25945999›Full record

ArticlePLoS pathogens2015

Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection.

Cláudio Nunes-Alves, Matthew G Booty, Stephen M Carpenter, Alissa C Rothchild, Constance J Martin, Danielle Desjardins, Katherine Steblenko, Henrik N Kløverpris, Rajhmun Madansein, Duran Ramsuran and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Multiple genetic paths including massive gene amplification allowProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TRAV1-2Communications biology · 2019
    Article
  15. Article
  16. Bystander CD8Nature · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Cláudio Nunes-AlvesDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Matthew G BootyDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Program in Immunology, Harvard Medical School, Boston, Massachusetts, United States of America.
Stephen M CarpenterDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Division of Infectious Disease, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Alissa C RothchildDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Program in Immunology, Harvard Medical School, Boston, Massachusetts, United States of America.
Constance J MartinDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Danielle DesjardinsDivision of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Katherine SteblenkoDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Henrik N KløverprisKwaZulu-Natal Research Institute for TB and HIV, Durban, South Africa; Nelson Mandela School of Medicine, University of Kwa-Zulu-Natal, Durban, South Africa; Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Rajhmun MadanseinNelson Mandela School of Medicine, University of Kwa-Zulu-Natal, Durban, South Africa.
Duran RamsuranKwaZulu-Natal Research Institute for TB and HIV, Durban, South Africa.
Alasdair LeslieKwaZulu-Natal Research Institute for TB and HIV, Durban, South Africa; Nelson Mandela School of Medicine, University of Kwa-Zulu-Natal, Durban, South Africa.
Margarida Correia-NevesLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Samuel M BeharDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Harvard University · USUniversity of KwaZulu-Natal · ZAUniversity of Massachusetts Chan Medical School · USUniversity of Minho · PTBrigham and Women's Hospital · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Regulation of CD8+ T cell immunity to tuberculosis (pending title)R01AI106725 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BEHAR, SAMUEL M · 2013 to 2022
$6.1M
NIAID NIH HHS P30 AI 060354NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI106725
6 · The paper itself

Abstract

The immune system can recognize virtually any antigen, yet T cell responses against several pathogens, including Mycobacterium tuberculosis, are restricted to a limited number of immunodominant epitopes. The host factors that affect immunodominance are incompletely understood. Whether immunodominant epitopes elicit protective CD8+ T cell responses or instead act as decoys to subvert immunity and allow pathogens to establish chronic infection is unknown. Here we show that anatomically distinct human granulomas contain clonally expanded CD8+ T cells with overlapping T cell receptor (TCR) repertoires. Similarly, the murine CD8+ T cell response against M. tuberculosis is dominated by TB10.44-11-specific T cells with extreme TCRβ bias. Using a retro genic model of TB10.44-11-specific CD8+ Tcells, we show that TCR dominance can arise because of competition between clonotypes driven by differences in affinity. Finally, we demonstrate that TB10.4-specific CD8+ T cells mediate protection against tuberculosis, which requires interferon-γ production and TAP1-dependent antigen presentation in vivo. Our study of how immunodominance, biased TCR repertoires, and protection are inter-related, provides a new way to measure the quality of T cell immunity, which if applied to vaccine evaluation, could enhance our understanding of how to elicit protective T cell immunity.

Indexed as

AnimalsAntigen PresentationCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHumansImmunodominant EpitopesInterferon-gammaLymphocyte ActivationMice, Inbred C57BLReceptors, Antigen, T-CellTuberculosisTuberculosis VaccinesEpitopes, T-LymphocyteImmunodominant EpitopesInterferon-gammaReceptors, Antigen, T-CellTuberculosis Vaccines

Identifiers

PMID25945999
PMCPMC4422591
OpenAlexW1801999888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.